Metraipolis › archive › dc_3fbc0c091e2e

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial — Europe PMC PMID:42174253

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42174253
DOI
10.1038/s41591-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-01T10:51:05.623Z
SHA-256 of the archived text
2d2cb1a18c3e525fddb394b97df64deedd3355ee1d4fc6e8a0d3af005740ac23
Stable URL of this page
https://metraipolis.com/documento/dc_3fbc0c091e2e

How to cite

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial — Europe PMC PMID:42174253 — Europe PMC (en), https://europepmc.org/article/MED/42174253 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fbc0c091e2e (Metraipolis archive dc_3fbc0c091e2e, sha256 2d2cb1a18c3e525fddb394b97df64deedd3355ee1d4fc6e8a0d3af005740ac23)
BibTeX
@misc{dc3fbc0c091e2e,
  title = {Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial — Europe PMC PMID:42174253},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42174253},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fbc0c091e2e; sha256 2d2cb1a18c3e525fddb394b97df64deedd3355ee1d4fc6e8a0d3af005740ac23},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42174253. Agents can read the archived copy with the MCP tool read_document.